Skip to main content
. 2019 Nov 14;10:2618. doi: 10.3389/fimmu.2019.02618

Table 1.

Clinical characteristics of subjects with NFKB1 mutations.

Family
ID
Subject
ID
Current age (years old) Age at first manifestation Age at first diagnosis of hypogamma-globulinemia Infections Autoimmune manifestations Lymphoproliferation Malignancy Other
Fam A S1 35 16 18 Recur. bronchitis and sinusitis Adult-onset Still's disease, AIHA Lymphadenopathy
Fam B S2 61 35 38 Recur. bronchitis, sinutitis, CMV-colitis (during R-CHOP) Splenomegaly, nodular lymphoid hyperplasia of the gastrointestinal tract, nodular regenerative hyperplasia of the liver Non-Hodgkin lymphoma Addison's disease, diabetes mellitus
type 2
S3 33 n.a. n.a. Asthma
S4 24 n.a. 18 Asthma
Fam C S5 56 50 52 Recur. bronchitis/ sinusitis
S6 50 37 40 Recur. gastrointestinal infections (S. enteritis), recur. warts, recur. bronchitis/ sinusitis
Fam D S7 61 42 53 Recur. pneumonias, recur. bronchitis/ sinusitis, ITP Lymphadenopathy, splenomegaly
Generalized shingles
Fam E S8 45 41 42 Pneumonia, otitis media, recur. bronchitis
S9 42 37 39 Recur. bronchitis, sinusitis. Pneumonia and sepsis through S. pnemoniae

n.a., not available; AIHA, autoimmune hemolytic anemia; ITP, idiopathic thrombocytopenic purpura; recur, recurrent; CMV, cytomegalovirus; R-CHOP, rituximab, cyclophosphamide, hydroxydaunorubicin, oncovin, prednisolone.